Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Ceram publishes two new white papers on multi-substituted hydroxyapatite

As part of its ongoing work on biocompatibility and bioactivity of Hydroxyapatite (HA), Ceram, the international materials technology company, has published two new white papers, ‘Regulatory Approval Testing of Hydroxyapatite’ and ‘Synthesis Methods of Hydroxyapatite’.

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

Gaining and maintaining regulatory approval of medical devices and materials, such as Hydroxyapatite (HA) can be a fraught, lengthy and complex process. Submission of data to regulatory bodies, for example the FDA (Food and Drug Administration), has to be credible and fully documented in order to ensure success.  In the regulatory approval white paper, Gemma Budd, Product Manager, Healthcare at Ceram, argues the case for using one supplier for regulatory approval testing, using the example of HA testing.

The other white paper looks at various synthesis methods of HA, including precipitation, sol-gel and self-propagating combustion and demonstrates the vast variability of HA synthesised by some of the most popular methodologies.

With its newly-patented technology, Ceram’s aim is to work with clients to develop HA with tailored bioactivity, both for bone replacement materials applications and for new drug delivery systems with tailored bio-application requirements.

The white papers are free to download from Ceram’s website at www.ceram.com/medical.

Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?